Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Innovative Pharmaceutical Biotech ( (HK:0399) ) has provided an announcement.
Starcoin Group Limited announced a supplemental update regarding their memorandum of understanding for a Token Issue. The company plans to engage Hong Kong legal advisors to ensure compliance with digital asset regulations and privacy considerations. The Token Issue is contingent upon receiving necessary legal confirmations and may involve licensed distributors. The company is still conducting legal reviews and has not yet consulted regulators, emphasizing that the Token Issue may or may not proceed. Stakeholders are advised to exercise caution as further developments are awaited.
More about Innovative Pharmaceutical Biotech
Starcoin Group Limited, formerly known as Innovative Pharmaceutical Biotech Limited, operates in the digital assets industry, focusing on token issuance and related services. The company is incorporated in the Cayman Islands and continued in Bermuda with limited liability.
Average Trading Volume: 16,367,699
Technical Sentiment Signal: Hold
Current Market Cap: HK$621.4M
For an in-depth examination of 0399 stock, go to TipRanks’ Overview page.